Literature DB >> 28114741

Loss of the transforming growth factor-β effector β2-Spectrin promotes genomic instability.

Jian Chen1, Vivek Shukla1,2, Patrizia Farci3, Jaclyn Andricovich4, Wilma Jogunoori5, Lawrence N Kwong6, Lior H Katz1,7, Kirti Shetty8, Asif Rashid9, Xiaoping Su10, Jon White5, Lei Li11, Alan Yaoqi Wang12, Boris Blechacz1, Gottumukkala S Raju1, Marta Davila1, Bao-Ngoc Nguyen13, John R Stroehlein1, Junjie Chen11, Sang Soo Kim14, Heather Levin13, Keigo Machida15,16, Hidekazu Tsukamoto15,17,18, Peter Michaely19, Alexandros Tzatsos4, Bibhuti Mishra5,13,20, Richard Amdur13,20, Lopa Mishra5,13,20.   

Abstract

Exposure to genotoxins such as ethanol-derived acetaldehyde leads to DNA damage and liver injury and promotes the development of cancer. We report here a major role for the transforming growth factor β/mothers against decapentaplegic homolog 3 adaptor β2-Spectrin (β2SP, gene Sptbn1) in maintaining genomic stability following alcohol-induced DNA damage. β2SP supports DNA repair through β2SP-dependent activation of Fanconi anemia complementation group D2 (Fancd2), a core component of the Fanconi anemia complex. Loss of β2SP leads to decreased Fancd2 levels and sensitizes β2SP mutants to DNA damage by ethanol treatment, leading to phenotypes that closely resemble those observed in animals lacking both aldehyde dehydrogenase 2 and Fancd2 and resemble human fetal alcohol syndrome. Sptbn1-deficient cells are hypersensitive to DNA crosslinking agents and have defective DNA double-strand break repair that is rescued by ectopic Fancd2 expression. Moreover, Fancd2 transcription in response to DNA damage/transforming growth factor β stimulation is regulated by the β2SP/mothers against decapentaplegic homolog 3 complex.
CONCLUSION: Dysfunctional transforming growth factor β/β2SP signaling impacts the processing of genotoxic metabolites by altering the Fanconi anemia DNA repair pathway. (Hepatology 2017;65:678-693).
© 2016 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28114741      PMCID: PMC5432427          DOI: 10.1002/hep.28927

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  33 in total

Review 1.  Smad transcription factors.

Authors:  Joan Massagué; Joan Seoane; David Wotton
Journal:  Genes Dev       Date:  2005-12-01       Impact factor: 11.361

2.  Assaying double-strand break repair pathway choice in mammalian cells using a targeted endonuclease or the RAG recombinase.

Authors:  David M Weinstock; Koji Nakanishi; Hildur R Helgadottir; Maria Jasin
Journal:  Methods Enzymol       Date:  2006       Impact factor: 1.600

3.  Defects in transforming growth factor-beta signaling cooperate with a Ras oncogene to cause rapid aneuploidy and malignant transformation of mouse keratinocytes.

Authors:  A Glick; N Popescu; V Alexander; H Ueno; E Bottinger; S H Yuspa
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

4.  A high susceptibility of Fanconi's anemia to chromosome breakage by DNA cross-linking agents.

Authors:  M S Sasaki; A Tonomura
Journal:  Cancer Res       Date:  1973-08       Impact factor: 12.701

5.  Human Fanconi anemia monoubiquitination pathway promotes homologous DNA repair.

Authors:  Koji Nakanishi; Yun-Gui Yang; Andrew J Pierce; Toshiyasu Taniguchi; Martin Digweed; Alan D D'Andrea; Zhao-Qi Wang; Maria Jasin
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-13       Impact factor: 11.205

6.  Transforming growth factor-beta signaling in stem cells and cancer.

Authors:  Lopa Mishra; Rik Derynck; Bibhuti Mishra
Journal:  Science       Date:  2005-10-07       Impact factor: 47.728

7.  Heterozygous mice for the transforming growth factor-beta type II receptor gene have increased susceptibility to hepatocellular carcinogenesis.

Authors:  Y H Im; H T Kim; I Y Kim; V M Factor; K B Hahm; M Anzano; J J Jang; K Flanders; D C Haines; S S Thorgeirsson; A Sizeland; S J Kim
Journal:  Cancer Res       Date:  2001-09-15       Impact factor: 12.701

8.  Hepatocellular expression of a dominant-negative mutant TGF-beta type II receptor accelerates chemically induced hepatocarcinogenesis.

Authors:  S Kanzler; E Meyer; A W Lohse; P Schirmacher; J Henninger; P R Galle; M Blessing
Journal:  Oncogene       Date:  2001-08-16       Impact factor: 9.867

9.  To the rescue: the Fanconi anemia genome stability pathway salvages replication forks.

Authors:  George-Lucian Moldovan; Alan D D'Andrea
Journal:  Cancer Cell       Date:  2012-07-10       Impact factor: 31.743

10.  Progenitor/stem cells give rise to liver cancer due to aberrant TGF-beta and IL-6 signaling.

Authors:  Yi Tang; Krit Kitisin; Wilma Jogunoori; Cuiling Li; Chu-Xia Deng; Susette C Mueller; Habtom W Ressom; Asif Rashid; Aiwu Ruth He; Jonathan S Mendelson; John M Jessup; Kirti Shetty; Michael Zasloff; Bibhuti Mishra; E P Reddy; Lynt Johnson; Lopa Mishra
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-08       Impact factor: 11.205

View more
  17 in total

1.  Analysis of Genomes and Transcriptomes of Hepatocellular Carcinomas Identifies Mutations and Gene Expression Changes in the Transforming Growth Factor-β Pathway.

Authors:  Jian Chen; Sobia Zaidi; Shuyun Rao; Jiun-Sheng Chen; Liem Phan; Patrizia Farci; Xiaoping Su; Kirti Shetty; Jon White; Fausto Zamboni; Xifeng Wu; Asif Rashid; Nagarajan Pattabiraman; Raja Mazumder; Anelia Horvath; Ray-Chang Wu; Shulin Li; Cuiying Xiao; Chu-Xia Deng; David A Wheeler; Bibhuti Mishra; Rehan Akbani; Lopa Mishra
Journal:  Gastroenterology       Date:  2017-09-15       Impact factor: 22.682

2.  The functional importance of lamins, actin, myosin, spectrin and the LINC complex in DNA repair.

Authors:  Muriel W Lambert
Journal:  Exp Biol Med (Maywood)       Date:  2019-10-04

Review 3.  The Spectrinome: The Interactome of a Scaffold Protein Creating Nuclear and Cytoplasmic Connectivity and Function.

Authors:  Steven R Goodman; Daniel Johnson; Steven L Youngentob; David Kakhniashvili
Journal:  Exp Biol Med (Maywood)       Date:  2019-09-04

4.  β2-spectrin (SPTBN1) as a therapeutic target for diet-induced liver disease and preventing cancer development.

Authors:  Shuyun Rao; Xiaochun Yang; Kazufumi Ohshiro; Sobia Zaidi; Zhanhuai Wang; Kirti Shetty; Xiyan Xiang; Md Imtaiyaz Hassan; Taj Mohammad; Patricia S Latham; Bao-Ngoc Nguyen; Linda Wong; Herbert Yu; Yousef Al-Abed; Bibhuti Mishra; Michele Vacca; Gareth Guenigault; Michael E D Allison; Antonio Vidal-Puig; Jihane N Benhammou; Marcus Alvarez; Päivi Pajukanta; Joseph R Pisegna; Lopa Mishra
Journal:  Sci Transl Med       Date:  2021-12-15       Impact factor: 17.956

5.  Validation of Anticorrelated TGFβ Signaling and Alternative End-Joining DNA Repair Signatures that Predict Response to Genotoxic Cancer Therapy.

Authors:  Ines Guix; Qi Liu; Miquel Angel Pujana; Patrick Ha; Josep Piulats; Isabel Linares; Ferran Guedea; Jian-Hua Mao; Ann Lazar; Jocelyn Chapman; Sue S Yom; Alan Ashworth; Mary Helen Barcellos-Hoff
Journal:  Clin Cancer Res       Date:  2022-04-01       Impact factor: 13.801

Review 6.  Exploiting Canonical TGFβ Signaling in Cancer Treatment.

Authors:  Qi Liu; Genwen Chen; Jade Moore; Ines Guix; Dimitris Placantonakis; Mary Helen Barcellos-Hoff
Journal:  Mol Cancer Ther       Date:  2021-10-20       Impact factor: 6.009

Review 7.  Spectrin and its interacting partners in nuclear structure and function.

Authors:  Muriel W Lambert
Journal:  Exp Biol Med (Maywood)       Date:  2018-03

8.  Mutated CEACAMs Disrupt Transforming Growth Factor Beta Signaling and Alter the Intestinal Microbiome to Promote Colorectal Carcinogenesis.

Authors:  Shoujun Gu; Sobia Zaidi; Md Imtaiyaz Hassan; Taj Mohammad; Tathiane M Malta; Houtan Noushmehr; Bryan Nguyen; Keith A Crandall; Jigisha Srivastav; Vincent Obias; Paul Lin; Bao-Ngoc Nguyen; Michael Yao; Ren Yao; Charles Hadley King; Raja Mazumder; Bibhuti Mishra; Shuyun Rao; Lopa Mishra
Journal:  Gastroenterology       Date:  2019-10-01       Impact factor: 22.682

Review 9.  The role of ALDH2 in tumorigenesis and tumor progression: Targeting ALDH2 as a potential cancer treatment.

Authors:  Hong Zhang; Liwu Fu
Journal:  Acta Pharm Sin B       Date:  2021-02-11       Impact factor: 11.413

10.  PRAJA is overexpressed in glioblastoma and contributes to neural precursor development.

Authors:  Joshua Shin; Viveka Mishra; Eric Glasgow; Sobia Zaidi; Jian Chen; Kazufumi Ohshiro; Bhargava Chitti; Amee A Kapadia; Neha Rana; Lopa Mishra; Chu-Xia Deng; Shuyun Rao; Bibhuti Mishra
Journal:  Genes Cancer       Date:  2017-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.